Data Scientist (R5-R7)

Indianapolis, Indiana, United States

Auto‑apply with AI Apply

Not SpecifiedCompensation

Junior (1 to 2 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Candidates must possess a Ph.D. in Statistics, Computational Finance, Economics, Mathematics, Computer Science, or a related quantitative field, along with a minimum of 2 years of academic or employment experience leveraging statistics and machine learning techniques to inform business strategy. Experience must include at least 2 years with frameworks for developing machine learning models, 2 years with tree-based machine learning models (including XGBoost and LGBM) and deep neural networks (including convolutional neural networks and recurrent neural networks), 2 years with technical collaboration tools, including GitHub, 2 years with programming languages, including R and Python, 1 year translating business needs into analytics problems, and 1 year managing and processing large data sets, including data cleaning, augmentation, and annotation.

Responsibilities

The Data Scientist will provide data analytics, statistics, and machine learning support for healthcare provider (HCP) sales and marketing operations, leveraging artificial intelligence and machine learning (AI/ML) techniques to develop analytics solutions and inform business strategy. They will develop data modeling capabilities to provide insights on marketing mix, attribution, channel and spend optimization, and prescriptive analytics, build model pipelines and integrate results into business outcomes, scale current data pipelines and increase automation of AI/ML deliverables, and ensure alignment of AI/ML techniques with stakeholder objectives and goals.

Skills

Statistics

Machine Learning

Artificial Intelligence

Data Modeling

Data Pipelines

Automation

AI/ML Techniques

Model Development

Tree-Based Models (XGBoost, LGBM)

Deep Neural Networks (CNN, RNN)

GitHub

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free